POOR PROGNOSIS FOR CHEMOTHERAPY OF METASTATIC PROSTATE-CANCER

被引：0

|

作者：

GELDOF, AA

RAO, BR

DEVOOGT, HJ

机构：

[1] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,DEPT ENDOCRINOL,1007 MC AMSTERDAM,NETHERLANDS

[2] FREE UNIV AMSTERDAM,ACAD ZIEKENHUIS,DEPT UROL,1007 MC AMSTERDAM,NETHERLANDS

来源：

ANTICANCER RESEARCH | 1985年 / 5卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：579 / 580

页数：2

相关论文

共 50 条

[1] PROSTATE-SPECIFIC ANTIGEN AND PROGNOSIS IN PATIENTS WITH METASTATIC PROSTATE-CANCER - A MULTIVARIABLE ANALYSIS OF PROSTATE-CANCER MORTALITY
REYNARD, JM
PETERS, TJ
GILLATT, D
BRITISH JOURNAL OF UROLOGY, 1995, 75 (04): : 507 - 515
[2] PROGNOSIS IN PROSTATE-CANCER
不详
CANADIAN FAMILY PHYSICIAN, 1992, 38 : 2568 - 2568
[3] THE PROGNOSIS FOR PROSTATE-CANCER
ZAPPA, F
NATURE GENETICS, 1994, 6 (03) : 215 - 216
[4] CHEMOTHERAPY FOR PROSTATE-CANCER
EISENBERGER, M
WORLD JOURNAL OF UROLOGY, 1990, 8 (01) : 40 - 46
[5] PROSTATE-CANCER - CHEMOTHERAPY
GIBBONS, RP
CANCER, 1987, 60 (03) : 586 - 588
[6] DISSEMINATED INTRAVASCULAR COAGULATION, A SIGN OF PROSTATE-CANCER WITH AN ESPECIALLY POOR PROGNOSIS
TREMEAUX, JC
NABHOLTZ, JM
CAILLOT, D
CUISENIER, J
GUERRIN, J
BRIET, S
BULLETIN DU CANCER, 1988, 75 (07) : 652 - 652
[7] STAGING AND PROGNOSIS OF PROSTATE-CANCER
DENIS, LJ
EUROPEAN UROLOGY, 1993, 24 : 13 - 18
[8] 15 YEARS EXPERIENCE OF COMBINED HORMONE CHEMOTHERAPY IN METASTATIC PROSTATE-CANCER
SERVADIO, C
MUKAMEL, E
NUSSBAUM, B
UROLOGY, 1992, 39 (03) : 274 - 276
[9] APPLICATIONS OF CHEMOTHERAPY FOR PROSTATE-CANCER
MURPHY, GP
SLACK, NH
CANCER DETECTION AND PREVENTION, 1979, 2 (04): : 785 - 797
[10] CHEMOTHERAPY IN METASTASIZED PROSTATE-CANCER
HEIMBACH, D
WIRTH, M
FROHMULLER, H
UROLOGE-AUSGABE A, 1991, 30 (05): : 329 - 332

← 1 2 3 4 5 →